NYMC Faculty Publications
Myasthenic Crisis in the Setting of Coronavirus Disease 2019 (COVID-19)
DOI
10.1016/j.jclinane.2020.110001
Journal Title
Journal of Clinical Anesthesia
First Page
110001
Last Page
110001
Document Type
Case Report
Publication Date
12-1-2020
Department
Anesthesiology
Keywords
Aged, 80 and over, COVID-19, Disease Progression, Humans, Male, Myasthenia Gravis, Pandemics, Respiratory Insufficiency, Tracheostomy
Disciplines
Anesthesiology | Critical Care | Infectious Disease | Medicine and Health Sciences
Abstract
-
A patient with Myasthenia Gravis (MG) on immunosuppressive therapy with underlying respiratory compromise may be more susceptible to infection with COVID-19 or severe manifestations of the virus.
-
It is theorized that patients with MG may be more vulnerable to bacterial and viral infections, due to respiratory muscle weakness and use of immunosuppressive medications.
-
It is critical for practitioners to be prepared for severe respiratory compromise in patients with MG and concomitant COVID-19 superinfection.
- In light of the COVID-19 pandemic, MG patients should be encouraged to continue their current treatment regimens, but engage in extra vigilant social distancing.
Recommended Citation
Salik, I., Rodhouse, H. B., & Barst, S. (2020). Myasthenic Crisis in the Setting of Coronavirus Disease 2019 (COVID-19). Journal of Clinical Anesthesia, 67, 110001-110001. https://doi.org/10.1016/j.jclinane.2020.110001
